Clinical Trial Update: Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy [NA]

View source ↗

Summary

This clinical trial update reports on the efficacy assessment of mavacamten in patients with symptomatic latent obstructive hypertrophic cardiomyopathy, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Xu Liu | Conditions: HCM - Hypertrophic Cardiomyopathy, Mavacamten | NA | Status: ACTIVE_NOT_RECRUITING